CCSG Supplement: Strengthen the Research, Training, and Outreach Capacity

CCSG 补充：加强研究、培训和推广能力

• 批准号: 10891139
• 负责人: Giulio Francesco Draetta
• 金额: $ 20万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 1996
• 资助国家: 美国
• 起止时间: 1996-08-28 至 2024-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10891139
• 关键词: Administrative Supplement; Advanced Development; Affect; Age; Cancer Burden; Cancer Center; Cancer Center Support Grant; Cancer Patient; Education; Educational workshop; Employee; Funding; Funding Opportunities; Goals; Grant; Malignant Neoplasms; Minority; Mission; Morbidity - disease rate; Outcome; Patient Care; Persons; Population; Postdoctoral Fellow; Prevention; Principal Investigator; Research; Research Personnel; Resources; Science; Texas; Training; Training Programs; Training Support; Underrepresented Minority; University of Texas M D Anderson Cancer Center; Vision; cancer health disparity; career development; economic disparity; experience; graduate student; improved; mortality; outreach; pre-doctoral; programs; symposium; training opportunity; undergraduate education; undergraduate student

P30 Administrative Supplement to The University of Texas MD Anderson Cancer Center’s “Cancer Center Support Grant” (P30 CA016672 47, Principal Investigator: Peter T. Pisters, MD) PROJECT SUMMARY: This supplement proposes the implementation of a collaborative training program to connect underrepresented minority scholars with training navigators. Training navigators will help connect scholars to the Continuing Umbrella of Research Experiences (CURE) program. Our goals for this supplement funding period are to fund scholars’ career development activities, workshops, conferences, and certificates. Combining the rich resources of MD Anderson, the aims of this supplement are to: 1) Identify underrepresented minority scholars (predoctoral, postdoctoral fellows, or early-stage investigators); 2) Engage and provide training support to scholars; and 3) Leverage two existing TNs with expertise in career development and grant administration and hire a third TN with expertise in cancer health disparities and connection to CURE and Region 3 GMaP research, training, and funding opportunities. RELEVANCE: This supplement proposes the implementation and completion of a Training Navigation program, which will provide hands-on support to assist predoctoral and postdoctoral fellows and early-stage investigators with their educational advancement and career development activities.

德克萨斯大学医学博士安德森癌症中心的P30行政补充 中心支持赠款”（P30 CA016672 47，首席调查员：彼得·T·Pisters，医学博士） 项目摘要：该补充提案实施协作培训计划 将代表性不足的少数民族学者与培训导航员联系起来。培训导航员将有助于连接 持续的研究经验伞（CURE）计划的学者。我们为此补充的目标 资助期是为学者的职业发展活动，研讨会，会议和证书提供资金。 结合MD Anderson的丰富资源，该补充的目的是：1）确定 代表性不足的少数族裔学者（博士后，博士后研究员或早期调查人员）； 2）参与 并为学者提供培训支持； 3）利用两个现有的TNS在职业中具有专业知识 开发和授予管理，并雇用第三个TN，具有癌症健康分布方面的专业知识， 与CURE和3区GMAP研究，培训和资金机会的联系。 相关性：此补充提案实施和完成培训导航 计划，该计划将提供动手支持，以协助餐饮前和博士后研究员以及早期阶段 调查人员的教育进步和职业发展活动。

项目成果

p53R245W Mutation Fuels Cancer Initiation and Metastases in NASH-driven Liver Tumorigenesis.

• DOI: 10.1158/2767-9764.crc-23-0218
• 发表时间: 2023-12-29
• 期刊: Cancer research communications

Radiotherapy reimagined: Integrating nanomedicines into radiotherapy clinical trials.

• DOI: 10.1002/wnan.1867
• 发表时间: 2022-10
• 期刊: Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
• 作者: A. Duross;J. Phan;A. Lazar;Joshua M Walker;Alexander R. Guimaraes;Carole Baas;S. Krishnan;C. R. Thomas;Conroy Sun;A. Bagley

Association of Myelofibrosis Phenotypes with Clinical Manifestations, Molecular Profiles, and Treatments.

• DOI: 10.3390/cancers15133331
• 发表时间: 2023-06-24
• 期刊: Cancers
• 影响因子: 5.2

Convection Enhanced Delivery of the Oncolytic Adenovirus Delta24-RGD in Patients with Recurrent GBM: A Phase I Clinical Trial Including Correlative Studies.

• DOI: 10.1158/1078-0432.ccr-21-3324
• 发表时间: 2022-04-14
• 期刊: Clinical cancer research : an official journal of the American Association for Cancer Research

Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses.

• DOI: 10.1172/jci159402
• 发表时间: 2022-09-01
• 期刊: JOURNAL OF CLINICAL INVESTIGATION
• 影响因子: 15.9
• 作者: Romain, Gabrielle;Strati, Paolo;Rezvan, Ali;Fathi, Mohsen;Bandey, Irfan N.;Adolacion, Jay R. T.;Heeke, Darren;Liadi, Ivan;Marques-Piubelli, Mario L.;Solis, Luisa M.;Mahendra, Ankit;Vega, Francisco;Cooper, Laurence J. N.;Singh, Harjeet;Mattie, Mike;Bot, Adrian;Neelapu, Sattva S.;Varadarajan, Navin
• 通讯作者: Varadarajan, Navin